Hybrid (18)F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases

Conventional MRI has important limitations when assessing for progression of disease (POD) versus treatment-related changes (TRC) in patients with malignant brain tumors. We describe the observed impact and pitfalls of implementing (18)F-fluoroethyltyrosine ((18)F-FET) perfusion PET/MRI into routine...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Nathaniel J., Deaton, Tristan K., Territo, Wendy, Graner, Brian, Gauger, Andrew, Snyder, Scott E., Schulte, Michael L., Green, Mark A., Hutchins, Gary D., Veronesi, Michael C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2023
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315704/
https://www.ncbi.nlm.nih.gov/pubmed/37116915
http://dx.doi.org/10.2967/jnumed.122.265149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315704/
https://www.ncbi.nlm.nih.gov/pubmed/37116915
http://dx.doi.org/10.2967/jnumed.122.265149

Ejemplares similares